Walsall Joint Medicines Management ommittee Prescribing ... · Prescribing Update Newsletter May/June 2020 If you have any comments or suggestions about this or future editions please

Walsall Joint Medicines Management Committee

Prescribing Update Newsletter May/June 2020

If you have any comments or suggestions about this or future editions please contact: [email protected]

FORMULARY/JMMC UPDATES COVID response related: Anticoagulation DMARD monitoring End of Life Updated formularies: Blood Glucose Test Strips Pen Needles Formulary additions: fusidic acid (Eye) and acetylcysteine 10% (Eye—on specialist initiation).

Access formulary from: Walsall Joint Formulary 2020

MHRA Drug Safety Update For the latest drug safety updates, alerts recalls, access from the links: - Monthly newsletters - Latest drug and safety updates - Alerts and recalls for drugs and medical devices During COVID-19: COVID-19: new dedicated YellowCard reporting site Valproate Pregnancy Prevention Programme: temporary advice Immunomodulatory drugs & pregnancy prevention: temporary advice (for management of thalidomide, lenalidomide, and pomalidomide). Cyproterone acetate: new advice to minimise risk of meningioma Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, availa-bility of reversal agents Epipen Supply Update: All script validations have been lifted, pharmacies to order as normal and hold stock on shelves as appropriate, for all strengths.

NICE Clinical Knowledge Summaries (CKS) Provide primary care practitioners with a readily accessible summary of the current evidence base and practical guidance on best practice.

Quick answers to clinical questions

Developed on behalf of NICE Evidence based and always up to date Designed for primary care

professionals

NATIONAL FLU VACCINATION PROGRAMME 2020/2021 Letter on importance of flu vaccination delivery this year

Groups eligible:

• all children aged two to ten (but not eleven years or older) on 31 August 2020

• those aged six months to under 65 years in

clinical risk groups

• pregnant women

• those aged 65 years and over

• those in long-stay residential care homes

• carers

• close contacts of immunocompromised

individuals

• health/social care staff employed by a registered residential care/nursing home,

registered domiciliary care provider, or a voluntary hospice provider.

Controlled Drug Incident:

www.cdreporting.co.uk

NEW Accountable Officer: Amit Dawda

For queries contact: 01216 110813 or email

If you have any comments or suggestions about this or future editions please contact: [email protected]

Local Insulin Device Error Incident Patient discharged on pre-filled insulin pen previously using a re-usable pen

Hospital discharge did not state the type of device the patient had been discharged on which resulted in the GP practice con-

tinuing to supply cartridges for the re-usable pen. When the hospital supply finished, care staff went back to using the medi-

cation issued by the practice. Having become habited to using pre-filled pens, staff assumed practice had sent the wrong item.

(Leading to confusion and delay in patient receiving correct insulin).

This incident occurred due to: 1) discharge letter not clearly stating device patient had been discharged on 2) care staff lack of

knowledge & experience in difference between different devices. This serves as a reminder that not only is it important to

reconcile medication but also devices when a patient is discharged.

NHSE Updates After-care needs of inpatients re-covering from COVID-19

Management of patients with musculoskeletal and rheumatic conditions (on corticosteroids)

Apps/websites released: - ThinkNinja App mental health support for 10-18yrs - Digibete App aimed at children, young people and their families - MyType1Diabetes website for adults

Supply & Discontinuations Supply Disruption Alerts:

Phenelzine, Salazopyrin

(suppositories), Danazol, Zyban,

H2 Antagonists, Glibenclamide

(discontinued), Isoniazid

SPS: shortages/discontinuations

Mims: drug shortages tracker

PSNC: shortages latest news

Evorel Conti in stock

Penicillin Allergy Documentation

Improving allergy documentation has been highlighted as a key area to mitigate the potential increased antimicrobial resistance that may have occurred during the recent pandemic. If the following information is rec-orded on the patients GP records this can be used to inform decision mak-ing. This will potentially reduce inappropriate use of broad spectrum anti-biotics, lead to better outcomes, reduce resistance and lead to significant cost savings.

When documenting a new allergy include the following information:

Severity

1 What is the nature of the allergy? (is it an adverse reaction or a true allergy?)

2 What are the details of the reaction?

3 How was the reaction managed? What was the outcome?

Timing

4 How many hours after having the first dose of the antibiotic did the reaction occur?

5 How many years ago did the reaction occur?

Tolerance

6 What other antibiotics have been tolerated since the reaction?

Medication Error Reporting:

Email to: [email protected]

National reporting and learning system: https://

report.nrls.nhs.uk/GP_eForm (including near misses)

BMJ Article: Assessment & management of asthma in

adults covid-19 pandemic

Open Prescribing Blog Effects on Prescribing COVID-19

NICE recommendations for migraines: Fremanezumab

RDTC: Vitamin D and infection risk (COVID-19) Guidance

Evidence on link is limited, usual advice applies.